What is AMPH's revenue growth forecast for 2024-2026?
(
NASDAQ
:
AMPH
)
Amphastar Pharmaceuticals
's forecast annual revenue growth rate of
9.65%
is
forecast to beat the
US
Drug Manufacturers - Specialty & Generic
industry's average forecast revenue growth rate of
6.41%
, and
it is also
forecast to beat the
US
market's average forecast revenue growth rate of
9.32%
.
Amphastar Pharmaceuticals
's revenue in
2024
is
$712,891,000
.
On average, 4 Wall Street analysts forecast AMPH's revenue for 2024 to be $36,506,136,363, with the lowest AMPH revenue forecast at $35,689,112,690, and the highest AMPH revenue forecast at $37,611,320,901. On average, 3 Wall Street analysts forecast AMPH's revenue for 2025 to be $40,490,495,772, with the lowest AMPH revenue forecast at $39,515,032,300, and the highest AMPH revenue forecast at $41,224,527,168.
In 2026, AMPH is forecast to generate $46,015,688,328 in revenue, with the lowest revenue forecast at $41,982,409,717 and the highest revenue forecast at $51,265,375,730.
